NPM1 and acute myeloid leukemia: Furthermore, the prognostic significance of genetic alterations was reflected by the incorporation of NPM1 mutations with adverse-risk cytogenetics into the adverse risk group, based on a meta-analysis correlating NPM1-mutated AML with adverse cytogenetic abnormalities with a poor outcome [12].